Goldman gave clients a list of stocks that may surge if a coronavirus vaccine is approved
September 06, 2020 at 09:51 AM EDT
With several Covid-19 vaccines in Phase 3 trials, Goldman Sachs is preparing its clients for a rebound in certain stocks.